Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000965314 | SCV001112579 | benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000965314 | SCV001892544 | benign | not provided | 2021-03-22 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22135386) |
Ambry Genetics | RCV002400121 | SCV002709718 | benign | Cardiovascular phenotype | 2020-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003916181 | SCV004739795 | likely benign | LMF1-related disorder | 2021-03-08 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001701385 | SCV001926224 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701385 | SCV001967154 | benign | not specified | no assertion criteria provided | clinical testing |